Filing metadata

Accession number
0001209191-21-028173
Form type
Form 3
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
Apr 23, 2021
Reporting period
Apr 23, 2021
Description
Initial ownership

Explore SEC Filings Hub